Uncategorized
New consensus document tackles nonstatin therapies for LDL reduction
In a new expert consensus statement, the American College of Cardiology recommends trying lifestyle and statin therapies before nonstatin medical therapies in patients who require LDL lowering to manage cardiovascular disease risk.“While evidence-based statin therapy remains the first-line standard of care for patients at risk for atherosclerotic [CVD], clinicians and patients may seek firmer and more specific guidance on adequacy of statin therapy and whether or when to use nonstatin therapies if response to statins is deemed inadequate,” writing committee chair Donald M. Lloyd-Jones, MD, ScM, FACC, chair of the (Read more...)